DNA methylation and primary immune thrombocytopenia

14Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

DNA methylation is a heritable, stable, and also reversible way of DNA modification; it can regulate gene expression without changing the nucleotide sequences. Because it takes part in regulation of immune responses, the loss of methylation homeostasis in immune cells will result in autoimmune disease by inducing aberrant gene expression. Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease with many immune deficiencies. Recently, it was well documented that abnormal DNA methylation is also involved in the etiology of ITP. In this review, we elucidate the role of DNA methylation in autoimmune diseases by summarizing the DNA methylation-sensitive genes and the relationship between DNA methylation and ITP. © 2013 Elsevier Inc.

Cite

CITATION STYLE

APA

Li, H., Xuan, M., & Yang, R. (2013). DNA methylation and primary immune thrombocytopenia. Seminars in Hematology, 50(SUPPL.1). https://doi.org/10.1053/j.seminhematol.2013.03.022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free